Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug

Journal of Microencapsulation

Volumn 30, Issue 2, 2013, Pages 173-180

  Zhai, Qing Zhou ^a  

^a CHANGCHUN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Host guest nanocomposite material; Mesoporous MCM 41; Propranolol hydrochloride; Slow release

Indexed keywords

MCM 41; NITROGEN; PROPRANOLOL;

ARTICLE; CONTROLLED RELEASE FORMULATION; DESORPTION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; INFRARED SPECTROSCOPY; INTESTINE FLUID; LOW TEMPERATURE; PARTICLE SIZE; POROSITY; SCANNING ELECTRON MICROSCOPY; STOMACH JUICE; STOMACH PH; TRANSMISSION ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

ADRENERGIC BETA-ANTAGONISTS; ADSORPTION; BODY FLUIDS; DELAYED-ACTION PREPARATIONS; HUMANS; MODELS, BIOLOGICAL; PARTICLE SIZE; POROSITY; PROPRANOLOL; SILICON DIOXIDE;

EID: 84873054577     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.714409     Document Type: Article

References (26)

1. Andersson J, Rosenholm J, Areva S, Linden M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater, 2004;16(21):4160-7.
2. Azais T, Hartmeyer G, Quignard S, Laurent G, Tourne-Peteilh C, Devoisselle JM, Babonneau F. Solid-state NMR characterization of drug-model molecules encapsulated in MCM-41 silica. Pure Appl Chem, 2009;81(8):1345-55.
3. Barrett E, Joyner LG, Halenda PP. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J Am Chem Soc, 1951;73(1):373-80.
4. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, Chu TW. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc, 1992;114(27):10834-43.
5. Brunauer S, Emmett PH, Teller E. Adsorption of gases in multimolecular layers. J Am Chem Soc, 1938;60(2):309-19.
6. Charnay C, Begu S, Tourne-Peteilh C, Nicole L, Lerner DA, Devoisselle JM. Inclusion of ibuprofen in mesoporous templated silica: Drug loading and release property. Eur J Pharm Biopharm, 2004;57(3):533-40.
7. Corma A. From microporous to mesoporous molecular sieve materials and their use in catalysis. Chem Rev, 1997;97(6):2373-420.
8. Doadrio AL, Sousa EMB, Doadrio JC, Perez Pariente J, Izquierdo-Barba I, Vallet-Regi M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release, 2004;97(1):125-32.
9. Doadrio JC, Sousa EMB, Izquierdo-Barba B, Doadrio AL, Perez-Pariente J, Vallet-Regi M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem, 2006;16(3):462-6.
10. Fassihi AR, Ritschel WA. Multiple-layer, direct-compression, controlledrelease system: In vitro and in vivo evaluation. J Pharm Sci, 1993;82(7):750-4.
11. Gao L, Zhang QH, Zhang WP, Guo JK. Preparation, characterization and photocatalytic properties of singly and doubly titania-modified mesoporous silicate MCM-41 by varying titanium precursors. J Mater Chem, 2011;11:578-83.
12. Ghedini E, Signoretto M, Pinna FA, Doadrio L, Pariente JP, Martinez A, Babonneau F, Vallet-Regi M. Controlled release of metoprolol tartrate from nanoporous silica matrices. Microporous Mesoporous Mater, 2010;132(1-2):258-67.
13. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52(12):1145-7.
14. Horcajada P, Ramila A, Perez-Pariente J, Vallet-Regi M. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater, 2004;68:105-9.
15. Kim HJ, Ahn JE, Haam SJ, Shul YG, Song SY, Tatsumi T. Synthesis and characterization of mesoporous Fe/SiO2 for magnetic drug targeting. J Mater Chem, 2006;16(9):1617-21.
16. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic AYW. J Biomed Mater Res, 1990;24(6):721-34.
17. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieve synthesized by a liquid-crystal template mechanism. Nature, 1992;359:710-12.
18. Ramila A, Munoz B, Perez-Pariente J, Vallet-Regi M. Mesoporous MCM-41 as drug host system. J Sol-Gel Sci Tech, 2003;26:1199-202.
19. Song SM, Wang ZL, Li WB. 1993. Physical chemistry. Beijing: Higher Education Publish House, pp. 219-31.
20. Sultan SM. Kinetic determination of propranolol in drug formulations. Analyst, 1988;113:149-52.
21. Tang QL, Xu Y, Wu D, Sun YH. A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J Solid State Chem, 2006;179:1513-20.
22. Vallet-Regi M, Doadrio JC, Doadrio AL, Izquierdo-Barba B, Perez-Pariente J. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics, 2004;172(1-4):435-9.
23. Vallet-Regi M, Ramila A, del Real R, Perez-Pariente P. A new property of MCM-41: Drug delivery system. Chem Mater, 2001;13:308-11.
24. Yang LB, Fassihix AR. Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. J Pharm Sci, 1996;85(2):170-3.
25. Zendehdel M, Pouramini M, Alikhani H. Interaction study between drugs and some synthetic nanoporous composites. Inorg Mater, 2011;47(1):80-6.
26. Zhu YF, Shi JL. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous Mesoporous Mater, 2007;103(1-3):243-9.